UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2006-06, Vol.50 (6), p.2137-2145

2006

Volltextzugriff (PDF)

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments

The Lancet infectious diseases, 2013-03, Vol.13 (3), p.269-275

2013

Volltextzugriff (PDF)

Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells

Antimicrobial Agents and Chemotherapy, 2007-12, Vol.51 (12), p.4255-4260

2007

Volltextzugriff (PDF)

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

Journal of antimicrobial chemotherapy, 2005-03, Vol.55 (3), p.283-288

2005

Volltextzugriff (PDF)

Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact

The Journal of infectious diseases, 2005-06, Vol.191 (12), p.2149-2152

2005

Volltextzugriff (PDF)

Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin

Antimicrobial Agents and Chemotherapy, 2006-04, Vol.50 (4), p.1581-1585

2006

Volltextzugriff (PDF)

Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia

Clinical infectious diseases, 2008-04, Vol.46 (8), p.1142-1151

2008

Volltextzugriff (PDF)

Rapid Bactericidal Activity of Daptomycin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Peritonitis in Mice as Measured with Bioluminescent Bacteria

Antimicrobial Agents and Chemotherapy, 2007-05, Vol.51 (5), p.1787-1794

2007

Volltextzugriff (PDF)

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1714-1718

2003

Volltextzugriff (PDF)

Associations between the Genotypes of Staphylococcus aureus Bloodstream Isolates and Clinical Characteristics and Outcomes of Bacteremic Patients

Journal of Clinical Microbiology, 2008-09, Vol.46 (9), p.2890-2896

2008

Volltextzugriff (PDF)

Evaluation of Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus Developing Nonsusceptibility to Daptomycin

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.220-224

2008

Volltextzugriff (PDF)

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

The European respiratory journal, 2013-05, Vol.41 (5), p.1107-1115

2013

Volltextzugriff (PDF)

In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin

International journal of antimicrobial agents, 2006-11, Vol.28 (5), p.385-388

2006

Volltextzugriff (PDF)

Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

The Lancet infectious diseases, 2020-03, Vol.20 (3), p.330-340

2020

Volltextzugriff (PDF)

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results

The European respiratory journal, 2012-07, Vol.40 (1), p.17-27

2012

Volltextzugriff (PDF)

Design, Synthesis, and Antimicrobial Activity of 6-O-Substituted Ketolides Active against Resistant Respiratory Tract Pathogens

Journal of medicinal chemistry, 2000-03, Vol.43 (6), p.1045-1049

2000

Volltextzugriff (PDF)

Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Volltextzugriff (PDF)

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

The Journal of infectious diseases, 2019-05, Vol.219 (10), p.1536-1544

2019

Volltextzugriff (PDF)

Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model of Enterococcus faecalis and Enterococcus faecium Renal Infection

Antimicrobial Agents and Chemotherapy, 2003-11, Vol.47 (11), p.3561-3566

2003

Volltextzugriff (PDF)

In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates

Diagnostic microbiology and infectious disease, 2008-07, Vol.61 (3), p.339-342

2008

Volltextzugriff (PDF)

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

The Journal of infectious diseases, 2019-05, Vol.219 (10), p.1536-1544

2019

Volltextzugriff (PDF)

The Clinical Relevance and Correct Designation of Isolates Nonsusceptible to Daptomycin

Clinical infectious diseases, 2005-08, Vol.41 (3), p.411-412

2005

Volltextzugriff (PDF)

In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016

Diagnostic microbiology and infectious disease, 2017-10, Vol.89 (2), p.151-157

2017

Volltextzugriff (PDF)

Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health

Clinical infectious diseases, 2016-03, Vol.62 (5), p.603-607

2016

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(35)
Humans
(25)
Microbiology
(24)
Biological And Medical Sciences
(23)
Infectious Diseases
(22)
Medical Sciences
(22)
Anti-Bacterial Agents - Pharmacology
(17)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(15)
Pharmacology. Drug Treatments
(15)
Female
(14)
Microbial Sensitivity Tests
(14)
Male
(13)
Pharmacology & Pharmacy
(13)
Daptomycin - Pharmacology
(12)
Anti-Bacterial Agents - Therapeutic Use
(11)
Staphylococcus Aureus
(11)
Staphylococcus Aureus - Drug Effects
(11)
Immunology
(10)
Daptomycin
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments

Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact

Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin

Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia

Rapid Bactericidal Activity of Daptomycin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Peritonitis in Mice as Measured with Bioluminescent Bacteria

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

Associations between the Genotypes of Staphylococcus aureus Bloodstream Isolates and Clinical Characteristics and Outcomes of Bacteremic Patients

Evaluation of Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus Developing Nonsusceptibility to Daptomycin

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin

Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results

Design, Synthesis, and Antimicrobial Activity of 6-O-Substituted Ketolides Active against Resistant Respiratory Tract Pathogens

Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model of Enterococcus faecalis and Enterococcus faecium Renal Infection

In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

The Clinical Relevance and Correct Designation of Isolates Nonsusceptible to Daptomycin

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials

In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016

Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health

Suchergebnisse filtern